Attached files
file | filename |
---|---|
10-K - INTERLEUKIN GENETICS INC | v178350_10k.htm |
EX-23.1 - INTERLEUKIN GENETICS INC | v178350_ex23-1.htm |
EX-31.1 - INTERLEUKIN GENETICS INC | v178350_ex31-1.htm |
EX-21.1 - INTERLEUKIN GENETICS INC | v178350_ex21-1.htm |
EX-31.2 - INTERLEUKIN GENETICS INC | v178350_ex31-2.htm |
EX-10.23 - INTERLEUKIN GENETICS INC | v178350_ex10-23.htm |
EX-10.5.1 - INTERLEUKIN GENETICS INC | v178350_ex10-51.htm |
EX-10.5.2 - INTERLEUKIN GENETICS INC | v178350_ex10-52.htm |
EXHIBIT
32.1
CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(SUBSECTIONS (A)
AND (B) OF SECTION 1350, CHAPTER 63 OF TITLE 18,
UNITED
STATES CODE)
Pursuant
to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and
(b) of section 1350, chapter 63 of title 18 United States Code),
each of the undersigned officers of Interleukin Genetics, Inc., a Delaware
corporation (the “Company”), does hereby certify, to such officer’s knowledge,
that:
The
Annual Report on Form 10-K for the year ended December 31, 2009 (the
“Form 10-K”) of the Company fully complies with the requirements of
Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934,
and the information contained in the Form 10-K fairly presents, in all
material respects, the financial condition and results of operations of the
Company.
Date:
March 25, 2010
|
/s/ Lewis H.
Bender
|
Lewis
H. Bender
Chief
Executive
|
|
/s/ Eliot M.
Lurier
|
|
Date:
March 25, 2010
|
Eliot
M. Lurier
Chief
Financial Officer (Principal Financial and Accounting
Officer)
|
A signed
original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to the Company and will be
retained by the Company and furnished to the Securities and Exchange Commission
or its staff upon request.